# Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy

> **NCT04493073** · EARLY_PHASE1 · UNKNOWN · sponsor: **Asmaa Ahmed Ali Youssif** · enrollment: 100 (estimated)

## Conditions studied

- OCTA

## Interventions

- **PROCEDURE:** Trabectulectomy
- **DRUG:** Mitomycin
- **DEVICE:** Ologen Collagen Implant
- **DEVICE:** Mitomycin-C Kyowa®

## Key facts

- **NCT ID:** NCT04493073
- **Lead sponsor:** Asmaa Ahmed Ali Youssif
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493073, "Conjunctival Vascularity Changes Usnig OCTA After Trabeculectomy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04493073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*